Zhejiang Medicine Balance Sheet Health
Financial Health criteria checks 6/6
Zhejiang Medicine has a total shareholder equity of CN¥10.6B and total debt of CN¥749.2M, which brings its debt-to-equity ratio to 7.1%. Its total assets and total liabilities are CN¥13.4B and CN¥2.8B respectively. Zhejiang Medicine's EBIT is CN¥729.0M making its interest coverage ratio 79.8. It has cash and short-term investments of CN¥2.0B.
Key information
7.1%
Debt to equity ratio
CN¥749.20m
Debt
| Interest coverage ratio | 79.8x |
| Cash | CN¥1.96b |
| Equity | CN¥10.61b |
| Total liabilities | CN¥2.82b |
| Total assets | CN¥13.43b |
Recent financial health updates
Is Zhejiang Medicine (SHSE:600216) A Risky Investment?
Sep 14
Zhejiang Medicine (SHSE:600216) Has A Somewhat Strained Balance Sheet
Mar 29Recent updates
Zhejiang Medicine Co., Ltd. (SHSE:600216) Screens Well But There Might Be A Catch
Nov 22We Think That There Are Issues Underlying Zhejiang Medicine's (SHSE:600216) Earnings
Nov 01Is Zhejiang Medicine (SHSE:600216) A Risky Investment?
Sep 14What Zhejiang Medicine Co., Ltd.'s (SHSE:600216) 27% Share Price Gain Is Not Telling You
Aug 06Zhejiang Medicine (SHSE:600216) Is Reducing Its Dividend To CN¥0.15
Jul 05The Market Doesn't Like What It Sees From Zhejiang Medicine Co., Ltd.'s (SHSE:600216) Earnings Yet
Jun 21Zhejiang Medicine's (SHSE:600216) Earnings Are Weaker Than They Seem
May 02Zhejiang Medicine (SHSE:600216) Has A Somewhat Strained Balance Sheet
Mar 29Financial Position Analysis
Short Term Liabilities: 600216's short term assets (CN¥6.1B) exceed its short term liabilities (CN¥2.4B).
Long Term Liabilities: 600216's short term assets (CN¥6.1B) exceed its long term liabilities (CN¥462.0M).
Debt to Equity History and Analysis
Debt Level: 600216 has more cash than its total debt.
Reducing Debt: 600216's debt to equity ratio has reduced from 8% to 7.1% over the past 5 years.
Debt Coverage: 600216's debt is well covered by operating cash flow (122.2%).
Interest Coverage: 600216's interest payments on its debt are well covered by EBIT (79.8x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/31 04:49 |
| End of Day Share Price | 2024/12/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Zhejiang Medicine Co., Ltd. is covered by 14 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Xiaofeng Qiu | China International Capital Corporation Limited |
| Yilin Hou | China International Capital Corporation Limited |
| Zheng Zhou | China Merchants Securities Co. Ltd. |